InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Henderson Jane, Director. Insider active across 3 companies, notably Akero Therapeutics, Inc.. Aggregated, 10 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €485k. Activity tracked since 16 June 2023. The latest transaction was filed on 19 December 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
1,500 shares@ US$80.0028.2% of flowCommon StockSEC:0001104659-25-124354:0
9,398 sharesCommon StockSEC:0001193125-25-312098
9,398 sharesCommon StockSEC:0001193125-25-312098:0
3,000 shares@ US$7.0094.5% of flowCommon StockSEC:0000950170-25-107545:0
3,000 shares@ US$47.45730.8% of flowCommon StockSEC:0000950170-25-107545:1
6,000 shares@ US$48.2671.8% of flowCommon StockSEC:0001104659-24-092519:0
22,088 sharesCommon StockSEC:0001104659-23-080683:0
40,000 shares@ US$7.0164.7% of flowCommon StockSEC:0000950170-23-029228:0
14,588 sharesCommon StockSEC:0001410939-23-000073:0
7,500 sharesCommon StockSEC:0001410939-22-000070:0
10 of 10 declarations
About Henderson Jane
Jane Henderson is a Director at Akero Therapeutics, Inc. and IVERIC bio, Inc. She plays a key role in the governance of these companies, providing her expertise to guide strategic decisions. Her commitment is essential for their success.
